Across Canada, 20 companies have been recognised for their dedication to fostering employee well-being through pioneering ...

Chinese companies that shifted operations to South-East Asia to save costs while getting around Trump tariffs during his ...

Dipanjan Chatterjee, vice president and principal analyst at Forrester ... a new imported car will be easier for those with larger salaries to absorb. “That tax is more severe for people ...

Sukhinder Singh Cassidy is on track to be the second highest paid CEO on the ASX this year behind Macquarie's Shemara ...

Goldman Sachs' low P/E ratio, strong growth, and diverse income streams suggest potential stock outperformance and future ...

Goldman Sachs faces a challenging outlook with expected lower economic growth, impacting IPOs. Check out why I downgrade GS ...

On Tuesday, Goldman Sachs analyst Asad Haider upgraded shares of healthcare giant Johnson & Johnson (NYSE:JNJ) from "Neutral" to "Buy," simultaneously raising the price target to $172 from the ...

All of that adding up to a tough situation here in the oil markets. Joining us now to discuss is Goldman Sachs's co-head of global commodities research and head of oil research, Damien Courvalin.

Goldman Sachs analyst Catherine O’Brien lowered the firm’s price target on JetBlue (JBLU) to $3 from $5.50 and keeps a Sell rating on the shares. The firm reduced its outlook for the US ...

Investing.com-- Markets may still be underestimating the risk of a full-blown U.S. recession following the sharp escalation in tariffs on Chinese goods, Goldman Sachs analyst said in a note.

Goldman Sachs analyst Richard Law initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $30 price target The company’s lead asset, VK2735, is a dual GLP-1/GIP agonist being ...

Goldman Sachs analyst Karen Reichgott Fishman said the combination of diminishing U.S. economic exceptionalism and increased risk of recession supports a strategic move into safe-haven currencies.